Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jul 15;21(7):e0353157. doi: 10.1371/journal.pone.0353157

Chronic disease related emergency department presentations and potential for redirection to alternative acute care settings (“FOCUS” study): A nationwide flashmob study

Elisabeth M Mols 1,2,#, Michelle N Körnmann 3,4,*,#, Harm R Haak 1,2, Jelmer Alsma 5, Patricia M Stassen 6, Karin A H Kaasjager 7, Geert H Groeneveld 8, Marjolein N T Kremers 2,9; on behalf of the ORCA (Onderzoeks Consortium Acute Geneeskunde) Acute Medicine Research Consortium and Local Investigators
Editor: Vijayaprakash Suppiah10
PMCID: PMC13372115  PMID: 42455826

Abstract

Background

Emergency Departments (EDs) face increasing pressure, driven in part by the complex needs of an ageing population. Many internal medicine ED visits may reflect complications of chronic conditions. Aiming to maintain the accessibility of acute care, evaluation whether such presentations can be managed in alternative settings is necessary.

Methods

We conducted a prospective multicentre flashmob study in 28 Dutch hospitals over a 24-hour period (November 28th and 29th, 2024). All adult non-elective ED patients presenting for internal medicine were included. Primary outcomes were the proportion of visits related to chronic conditions and the potential for redirection to an alternative acute care facility. Data on patient characteristics, case complexity, and organisational factors were collected and analysed using descriptive and comparative statistics.

Results

Among 203 included patients, 45.3% presented with an acute complication of a chronic condition. Of these patients, 39.4% were receiving chronic care from an internist. Nearly one-quarter (24.1%) of all ED visits were considered preventable. Additionally, 39.9% of patients could have been managed in alternative settings such as acute outpatient clinics or directly to acute admission units. Despite the presence of these alternative care facilities in most hospitals, the lack of structural organisation was reported in 58.0% as a barrier to redirecting patients.

Conclusion

A substantial proportion of internal medicine patients at the ED reflect an acute on chronic care need. While alternative care pathways exist, organisational barriers hinder their use. Improving access to structured outpatient acute care could possibly reduce ED use and improve the efficiency of acute internal medicine services.

Introduction

The pressure on acute care is increasing, as illustrated by the rising number of overcrowded Emergency Departments (EDs) and ED diversions [1,2]. ED crowding is widely recognised as a complex, system-level problem resulting from a mismatch between demand and available capacity in the acute care chain [2,3]. Demographic changes, with an ageing population and a higher prevalence of multimorbidity, are often cited as one explanation, as they contribute to increasing care complexity and demand [2–5].These patients often require comprehensive diagnostics and hospital admission, resulting in prolonged ED length of stay (LOS) and downstream capacity constraints, which in turn exacerbates crowding [6].

Over recent decades, EDs have transformed into highly specialised environments designed to deliver rapid, high-intensity care for critically ill patients in need for specialised interventions. However, a shift in the acute care landscape has occurred, with an increasing number of patients presenting to the ED due to deterioration or complications of pre-existing chronic illnesses [7–9]. This group often represents a complex and vulnerable population, with higher rates of comorbidities, polypharmacy, and frailty [7]. For these patients, continuity of care within their chronic care network is essential to initiate timely and appropriate management. Moreover, a proportion of these patients presents with subacute care needs that may not require the full specialised capacity of the ED.

Given the ageing population, the evolving care demands and increasing case-complexity, ensuring the provision of the right care in the right setting is essential for maintaining a sustainable and future-proof acute care system. Achieving this requires insight into the type of patients presenting to the ED. The Dutch Society of Internal Medicine (NIV) has suggested that a substantial proportion of internal medicine ED visits are related to deterioration of chronic conditions, summarised in the phrase “Acute care is Chronic care” [10]. However, the exact proportion of such visits and the potential for redirection remains unclear. Addressing this knowledge gap is important, as pro-active management could prevent these acute presentations, supporting continuity of care and avoiding unnecessary ED use. For example, patients might be seen in alternative acute care settings, instead of the ED. In these settings, care could be provided by their own physician or by an acute internist, a specialist trained to manage complex acute internal medicine cases. Such redirection not only aligns with the principle of providing the right care in the right place, but is also increasingly important in the context of workforce shortages and ED overcrowding.

We conducted the FOCUS (Finding Optimal Care in Urgent Settings) study, a national multicentre flashmob-study, in which all patients presenting to the ED for internal medicine were analysed. The aim of this study was to quantify the proportion of ED visits related to chronic care trajectories and to assess the potential for redirection to alternative acute care settings, providing a foundation for optimising the delivery of care in the right place at the right time.

Methods

Study design

This study is an observational, cross-sectional, multicentre flashmob study conducted in the EDs of 28 Dutch hospitals, capturing a 24-hour snapshot of ED presentations. The study was conducted over a 24-hour period, from 08:00 on the 28th of November 2024 to08:00 on the 29th of November 2024. The flashmob method is a new way of conducting prospective research whereby relatively simple, but clinically relevant, questions can be answered in a short period of time [11]. Ethical approval was obtained from the Medical Ethics Review Committee (METC) of Máxima Medical Center (N24.040). Written informed consent was obtained before inclusion in the study.

Study setting

In the Netherlands, emergency care is provided in 79 EDs, of which 76 operate 24/7. General practitioners (GPs) have a strong gatekeeping role, and referral is very common for access to the ED [12]. Dutch EDs function as an open format department, providing acute care for all medical specialties. Upon presentation or after clinical assessment, patients are registered under a specific specialty (e.g., internal medicine) but may be assessed by an emergency physician (EP) or by a clinician from the corresponding specialty.

Study population

The study included all patients ≥18 years presenting to the ED for internal medicine (i.e., referred to internal medicine, triaged to internal medicine, or for whom the internist ultimately acted as the lead treating physician), encompassing all subspecialties, including endocrinology, haematology, infectious diseases, nephrology, oncology, rheumatology, vascular, allergy and immunology, and geriatric medicine, at participating hospitals during the study period. All eligible patients presenting during the study period were consecutively included, to minimise the risk of selection bias. To ensure a representative sample of hospital care, the study included patients from university, teaching, and general hospitals.

Study outcomes

The primary outcomes of this study were:

  1. The proportion of patients presenting with an acute complication, exacerbation or deterioration related to a chronic illness. For the purpose of this study, ‘complication’ refers to any complication, exacerbation or deterioration of a chronic condition, as assessed by the primary responsible physician.

  2. The proportion of patients under treatment with internal medicine, the GP, or other medical specialties, defined as those with at least one registered medical encounter within the preceding year.

  3. The proportion of ED visits that could have been redirected elsewhere in the emergency care chain or prevented, as retrospectively assessed by the primary responsible physician.

Secondary outcomes included organisational characteristics of acute care delivery, case complexity of patients presenting to the ED for internal medicine (determined by age, comorbidities, polypharmacy, and frailty), and the proportion of patients who had contact with the hospital within seven days prior to ED visit.

Data collection

Data were collected using Castor EDC. Before deployment, the electronic Case Report Form (eCRF) underwent pilot testing with practicing internists to ensure that all items were comprehensible and interpreted as intended. The eCRF consisted of two main components. First, a one-time organisational questionnaire was completed by the local investigators of all participating hospitals before the start of the study (S1 Questionnaire).

Second, patient level data were collected by the primary responsible physician at ED disposition through a separate eCRF, consisting of two sections (S2 Questionnaire). The first section captured clinical and demographic characteristics. The second section captured the primary responsible physicians assessment of the chronic disease related aspects of the presentation and the potential for alternative management. The primary responsible physician was asked to answer three key questions:

  1. Is the patient presenting with an acute deterioration of a chronic disease, a complication of the treatment of a chronic disease, or a complication related to a chronic disease?

  2. Do you think that the patient’s presentation to the ED, given the current organisation of care, could have been prevented?

  3. Could the patient, in theory, have been managed in a setting other than the ED for this complaint?

Definitions and variables of interest

Details on variables collected for organisational and patient characteristics are presented in Table 1.

Table 1. Definitions of variables.

Organisational characteristics
Hospital type University, Teaching, General
Internal medicine beds Theoretical number of beds (including subspecialties: acute medicine, infectious diseases, geriatrics, vascular medicine, allergology, endocrinology, hematology, nephrology, and oncology) in the hospital, irrespective of temporary closures (e.g., due to staffing shortages).
Acute care facility Presence of a dedicated acute medical unit, short‑stay unit or observation unit, and the maximum length of stay (LOS).
Alternative acute care facility Defined as facilities where patients with an acute care need can be assessed outside the ED (e.g., outpatient clinics, daycare units, inpatient wards).
Patient characteristics
Demographics Age, Sex
Urgency category Urgency ED levels were determined according to the NTS (Dutch Triage Standard) or MTS (Manchester Triage Standard): U0 (red) reanimation, U1 (orange) life threatening, U2 (yellow) highly urgent, U3 (green) urgent, U4-U5 (blue) non-urgent.
Number of medications Defined as prescribed medications (daily/weekly), drops, inhaled meds, and regular over-the-counter use (e.g., paracetamol).
Comorbidities Comorbidities were defined as the presence of one or more chronic medical conditions co‑existing with the index condition at the time of the ED visit, categorised as No, 1–5 or >5
Frailty Frailty was defined according to the Clinical Frailty Scale (CFS): 1–3 were combined as “fit”, 4–6 as “vulnerable to moderately frail” and 7–9 as “severely frail to terminally ill”.
Prior hospital contact Any hospital contact in the 7 days prior to the ED visit, including telephone contact, outpatient visits, ED visits or inpatient admissions.

Statistical analysis

We summarised baseline patient and hospital characteristics using descriptive statistics. Differences between patients with chronic and non-chronic care trajectories, complexity measures, and other outcomes were tested with Pearson’s chi-squared or Fisher’s exact tests for categorical variables, and independent samples t-tests or Mann-Whitney U tests for continuous variables, as appropriate. Hospital-level differences in acute care organisation were analysed using the same approach. A p-value of <0.05 was considered statistically significant. Analyses were performed in SPSS version 25 (IBM Corp, Armonk, NY, USA).

Results

Organisational characteristics

A total of 28 hospitals participated in the study, comprising 6 university hospitals, 14 teaching hospitals, and 8 general hospitals (Table 2). All participating hospitals had an ED operating 24/7. A total of 24 hospitals had an acute care facility for patient admissions, the majority of which were acute medical units (AMU).

Table 2. Organisational characteristics participating hospitals.

Total University hospital Teaching hospital General hospital
Hospital type 28 6 21.4% 14 50.0% 8 28.6%
Number of beds
 Internal medicine, mean (95% CI)* 65 (16–140) 92 (60–124) 69 (56–83) 36 (27–45)
 ED, Mean (95% CI)* 20 (7–36) 20 (15–25) 23 (18–27) 15 (11–19)
Present acute care facilities a
 No 4 14.3% 0 0.0% 1 7.1% 3 37.5%
 Acute medical unit 19 67.9% 5 83.3% 9 64.3% 5 62.5%
 Observation unit 5 17.9% 0 0.0% 4 28.6% 1 12.5%
 Short stay unit* 3 3.6% 3 33.3% 0 0.0% 0 0.0%
Maximum length of stay in acute care facility
 No 1 3.6% 0 0.0% 1 7.1% 0 0.0%
 24H 5 17.9% 1 16.7% 3 21.4% 1 12.5%
 48H 17 64.3% 5 83.3% 8 64.3% 4 50.0%
 72H 1 14.3% 0 0.0% 1 7.1% 0 0.0%
Alternative acute care facilities outside the ED a
 Acute outpatient clinicb 23 82.1% 6 100% 12 85.7% 5 62.5%
 Outpatient clinic treating physicianc 16 57.1% 4 66.7% 9 64.3% 3 37.5%
 Acute medical unit 9 32.1% 3 50,0% 4 28.6% 2 25.0%
 Day care unit 6 21.4% 1 16.7% 2 14.3% 3 37.5%
 Inpatient ward 7 25.0% 0 0.0% 5 35.7% 2 25.0%
 Otherd 4 14.3% 1 16.7% 2 14.3% 1 12.5%

*p ≤ 0.05.

aMultiple responses allowed, b Outpatient clinic for short-term assessment and management of urgent conditions.

cPossibility for urgent consultations with the patient’s treating specialist.

dOther: Acute service for oncology patients, sickle cell disease centre, specialist consult at the out-of-hours GP service.

Alternative acute care facilities were evaluated, with the acute outpatient clinic being the most commonly available, present in 23 hospitals (82.1%, Table 2). In a substantial proportion of these hospitals, patients could be seen by their treating physician. Other frequently mentioned alternative locations for acute care included inpatient wards and the outpatient day care unit.

Patient characteristics

A total of 203 patients were included across 28 hospitals, with each hospital enrolling between three to fifteen patients (Table 3). Inclusion rates, reported by 13 hospitals, ranged from 44.4% to 100% of all internal medicine presentations with a median of 79.8%. Median age was 69 years (IQR 53–79), with university hospitals having the youngest cohort (60 years; IQR 43–76) and teaching hospitals the oldest (70 years; IQR 57–80). The majority of patients were aged 65–79 (33.0%), with no significant age group differences across hospital types. Overall, 51.2% of patients were female. The medication number of medication used was 5, and most patients had 1–2 comorbidities (47.8%). Functional status (CSF score) was similar across groups, with 11.8% of all patients categorised as severely frail (CFS 7–9). Additionally, the majority of patients were triaged U2 and U3, with significant differences between hospitals. In general hospitals patients were mostly triaged as U3 and in teaching hospitals mostly as U2. The most frequent presenting complaint was fever (31.0%), followed by general malaise (8.9%) (S1 Table).

Table 3. Patient characteristics.

All patients University

hospital
Teaching

hospital
General

hospital
N= 203 40 124 39
Age, median (IQR) 69 (53–79) 60 (43–76) 70 (62–69) 68 (61–71)
Age-groups
 18-44 34 (16.7%) 10 (25.0%) 20 (16.1%) 4 (10.3%)
 45-64 54 (26.6%) 11 (27.5%) 30 (24.2%) 13 (33.3%)
 65-79 67 (33.0%) 12 (30.0%) 43 (34.7%) 12 (30.8%)
  ≥ 80 48 (23.6%) 7 (17.5%) 31 (25.0%) 10 (25.6%)
Sex (F) 104 (51.2%) 18 (45.0%) 66 (53.2%) 20 (51.3%)
Medication

median number (IQR)
5.0 (2.0-10.0) 8.0 (4-13) 5.5 (2-9) 5.0 (1-10)
  ≥ 5, n= (%) 122 (60.1%) 26 (65.0%) 74 (59.7%) 22 (56.4%)
Comorbidities
 No* 32 (15.8%) 1 (2.5%) 25 (20.2%) 6 (15.4%)
 1-2* 97 (47.8%) 15 (37.5%) 57 (46.0%) 25 (64.1%)
 3-4* 48 (23.6%) 16 (40.0%) 27 (21.8%) 5 (12.8%)
  ≥ 5 26 (12.8%) 8 (20.0%) 15 (12.1%) 3 (7.7%)
CFS
 1–3 120 (59.1%) 23 (57.5%) 78 (62.9%) 19 (48.7%)
 4–6 59 (29.1%) 12 (30.0%) 35 (28.2%) 12 (30.08%)
 7-9 24 (11.8%) 5 (12.5%) 11 (8.9%) 8 (20.5%)
Triage category
 U0 3 (1.5%) 2 (5.0%) 1 (0.8%) 0 (0.0%)
 U1 29 (14.3%) 8 (20.0%) 18 (14.5%) 3 (7.7%)
 U2 105 (51.7%) 21 (52.5%) 70 (56.5%) 14 (35.9%)
 U3* 59 (29.1%) 8 (20.0%) 29 (23.4%) 22 (56.4%)
 U4-5 7 (3.4%) 1 (2.5%) 6 (4.8%) 0 (0.0%)
LOS ED in minutes

median (IQR)
188 (142–240) 213 (160–286) 184 (141–241) 172 (132–209)

CFS: Clinical Frailty Scale, LOS: Length of Stay, ED: Emergency Department.

*p ≤ 0.05.

Half of the patients were referred by a GP (n = 106, 52.2%), with an internist consulted before referral in 62.6% (S2 Table). In university hospitals, referrals were more often made by in-hospital specialists (45.0%). Most referrals occurred during office hours (n = 144, 70.9%). Median LOS in the ED was significantly longer in university hospitals compared to general hospitals (213 minutes; IQR 160–286 vs. 172 minutes; IQR 132–209, p = 0.03). The majority of patients were admitted to the hospital (n = 123, 60.9%), and 73 patients (36.0%) were discharged home.

Acute on chronic care

A large number of patients (n = 92; 45.3%) presented with a complication of a chronic condition (Fig 1). Of all patients already under follow-up by an internist (n = 80; 39.4%), 68.8% presented to the ED with the same chronic condition. Among patients receiving care for a chronic condition from a GP or other medical specialist (n = 151; 74.0%), 44.7% presented to the ED for internal medicine with the same condition they were being treated for by these physicians.

Fig 1. Distribution and care pathways of patients presenting to the emergency department (ED).

Fig 1

Made at SankeyMATIC.com. GP: General Practitioner MS: Medical Specialist. (A) Pie chart showing the proportion of patients classified as Acute non-chronic (55%) versus Acute on chronic (45%). (B) Sankey diagram illustrating the flow of patients who are under chronic care of an internist or general practitioners/other medical specialists (GP/MS). Of these patients, 45% present with the same chronic condition, while 55% present with a different condition.

Most patients (n = 132, 62.0%) had no contact with hospital healthcare providers seven days before their ED-visit (S3 Table). Notably, patients at university hospitals were more likely to have prior hospital contact compared to other hospitals (51.2% vs. 34.1% and 37.5%, respectively). A small proportion of patients had either visited the ED (n = 9, 4.2%) or had been hospitalised (n = 11, 5.2%).

Redirecting urgent care

Following clinical assessment, the primary responsible physician was asked to retrospectively determine whether the ED presentation could have been prevented within the current organisation of care, or whether the patient could theoretically have been redirected to an alternative acute care setting, irrespective of existing care structures (Table 4). In 49 cases (24.1%) the ED visit was considered preventable, and 81 patients (39.9%) were judged as eligible for redirection to alternative acute care settings. Among patients who presented with a complication of a chronic condition, 48.9% of ED visits were judged to have the potential to be redirected to an alternative setting (S4 Table).

Table 4. Possible prevention and redirection of ED presentation.

Total University

hospital
Teaching

hospital
General

hospital
Possible prevention of ED presentation?
 No 154 (75.9%) 20 (64.5%) 97 (78.2%) 32(82.1%)
 Yes 49 (24.1%) 11 (35.5%) 27 (21.8%) 7 (17.9%)
Theoretical redirection to alternative setting possible?
 No * 122 (60.1%) 18 (45.0%) 88 (71.0%) 16 (41.0%)
 Yes * 81 (39.9%) 22 (55.0%) 36 (29.0%) 23 (59.0%)
Alternative care settings a, b
 Acute outpatient clinic * 63 (77.8%) 13 (59.1%) 30 (83.3%) 20(87.0%)
 Regular outpatient clinic 8 (9.9%) 2 (9.1%) 6 (16.7%) 0 (0.0%)
 Acute Medical Unit 22 (27.2%) 8 (36.4%) 9 (25.0%) 5 (21.7%)
 Inpatient ward* 12 (14.8%) 7 (31.8%) 2 (5.6%) 3 (13.0%)
 Outpatient day care unit 3 (3.7%) 2 (9,1%) 1 (2.7%) 0 (0.0%)
 GP 6 (7.4%) 2 (9.1%) 3 (8.3%) 1 (4.3%)
 Otherc 3 (3.7%) 0 (0.0%) 2 (5.6%) 1 (4.3%)
Reasons for inability to redirect to alternative settings a,b
 Administration 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 No staffing capacity * 12 (14.8%) 1 (4.5%) 3 (8.3%) 8 (34.8%)
 No available space * 12 (14.8%) 1 (4.5%) 2 (5.6%) 9 (39.1%)
 Not structurally organised 47 (58.0%) 15 (68.2%) 17 (47.2%) 15 (65.2%)
 Not a preference of the patient 3 (3.7%) 2 (9.1%) 1 (2.8%) 0 (0.0%)
 Due to after-hours presentation 14 (17.3%) 3 (13.6%) 6 (16.7%) 5 (21.7%)
 Referral via other healthcare provider 12 (14.8%) 2 (9.1%) 9 (25.0%) 1 (4.3%)
 Otherd 10 (12.3%) 1 (4.5%) 6 (16.7%) 3 (13.0%)

ED: Emergency Department, GP: General Practitioner.

*p ≤ 0.05.

aMultiple answers allowed b Proportion of patients considered eligible for redirection.

cOther, e.g., other clinic, procedure room, outpatient same day emergency care.

dOther, e.g., Inadequate inquiry of complaints by the GP, logistical reasons, no urgent lab tests at the acute outpatient clinic, and miscommunication among involved healthcare providers.

Most patients were considered suitable for redirection to an acute outpatient clinic (n = 63, 77.8%) or an AMU (n = 22, 27.2%). The main barrier to redirection was the lack of structurally organised acute care in alternative settings (n = 47, 58.0%), while only 14 patients (17.3%) were limited by out-of-hours presentation. Hospital contact within seven days prior to ED visit was more common among patients with preventable visits than non-preventable visits (n = 26; 53.1% vs. n = 45; 29.2%, p = 0.002), as was recent hospital admission (n = 6; 12.2% vs. n = 5; 3.2%, p = 0.02). Similarly, patients considered redirectable to alternative settings more often had prior hospital contact than non-redirectable patients (n = 39; 48.1% vs. n = 32; 26.2%, p = 0.001), and were more frequently referred by a hospital based specialist (n = 30; 37.0% vs n = 22; 18.0%, p = 0.001). An overview of this subgroup analysis is provided in S5 Table and S6 Table.

Comparison of primary outcomes by hospital inclusion rate

A comparison between hospitals with an inclusion rate below 50% (n = 4) and those with a 100% (n = 3) inclusion rate showed no statistically significant differences in primary outcomes. The proportion of patients with a chronic disease was 46.8% versus 53.0% (p = 0.915), preventable visits 30.5% versus 24.0% (p = 0.54), and redirectable visits 50.8% versus 42.2% (p = 0.54).

Discussion

In this nationwide observational flashmob study, we evaluated the characteristics of internal medicine ED presentations across 28 hospitals, focusing on chronic disease related visits and the potential for redirection to alternative acute care settings. We found that nearly half of the ED visits were due to an acute complication of a chronic condition, highlighting the overlap between acute and chronic care. In 24% of these cases, the visit was considered preventable and in nearly 40%, patients could potentially have been redirected to alternative acute care settings, as retrospectively judged by the primary responsible physician.

To the best of our knowledge, this is the first study investigating the hypothesis ‘acute care is chronic care’ in acute internal medicine patients. We found that almost half of the patients presented to the ED due to a complication of a chronic condition. In addition, 38.0% of patients had contact with a medical specialist seven days prior to their ED visit, including 4.2% who had visited the ED and 5.2% who had been admitted. Earlier research describes 7-day revisit rates between 2.6% and 14.4%, often driven by acute deterioration related to infection, cardiovascular disease or chronic kidney disease [13,14]. Together, these findings underscore the complexity of chronic care management across care settings and support the perspective that acute care increasingly serves as an extension of chronic care [4].

Furthermore, in addition to the high prevalence of chronic conditions, we found that patients presenting to the ED for internal medicine exhibited considerable care complexity, reflected in high rates of multimorbidity, polypharmacy, and frailty, further influenced by age and clinical urgency. These findings highlight the challenges of delivering acute care to patients with multiple and interacting health problems. This aligns with previous research indicating that acute medical patients often have complex health needs and multiple chronic conditions managed across specialties. For example, Buurman et al. reported that 87.8% of acutely hospitalised older adults had multimorbidity when both acute and chronic conditions were considered [15–17].

Our study found that 24% of ED visits were considered preventable based on retrospective assessment by healthcare professionals. In addition, approximately 40% of all ED visits, and nearly half of those related to a chronic condition, were considered theoretically manageable in a non-ED setting. These estimates should, however, be interpreted carefully, as the potential for redirection and preventability were assessed retrospectively after full ED evaluation and were based on the judgement of the primary responsible physician, which may vary between clinicians. Nevertheless, our findings are in line with previous studies in which ED physicians judged 31% and 23% of ED visits to be preventable [18,19]. As such, they provide a first indication that a substantial proportion of patients may be suitable for management in alternative acute care settings. This is particularly relevant because internal medicine patients constitute a substantial proportion of ED visits and their complex diagnostic work-up leads them to contribute disproportionately to ED crowding. Prevention or redirection of care in this group could therefore help alleviate system-wide congestion, even if they account for only one-quarter to one-fifth of the ED population. Interestingly, in both preventable and redirectable ED visits, patients were more likely to have had contact with the hospital prior to their ED presentation. These findings suggest that patients with preventable or redirectable ED visits are often already engaged in existing hospital-based care pathways. This is supported by a previous study showing an association between outpatient specialist contact up to one year prior to the ED visit and frequent ED use [20]. However, no studies have evaluated the relationship between hospital contact shortly before the ED visit and subsequent ED utilisation. Although based on relatively small numbers and derived from an exploratory 24-hour observational snapshot, our findings suggest that these prior contact moments may represent clinically relevant opportunities for earlier intervention. At the same time, they may also reflect failed attempts at redirection within existing care structures. Further research is warranted to understand the nature of recent hospital contacts and their potential role in preventing avoidable ED presentations and supporting alternative care pathways.

Lastly, 78% of patients suitable for redirection were judged potentially manageable in an acute outpatient clinic. This is particularly relevant given that most hospitals reported the availability of such a clinic. Several factors may contribute to this discrepancy. First, acute outpatient clinics may be insufficiently accessible or inadequately organised at the time of referral. This is further supported by the finding that redirectable patients were more often referred by hospital-based specialists, who are typically familiar with local acute care structures. Possible explanations include a lack of dedicated capacity for urgent cases, or logistical barriers such as limited timely access to diagnostics or insufficient staffing. Indeed, structural issues were the most frequently reported barrier to redirecting patients to alternative care settings. Second, it may be difficult to identify suitable patients for redirection in advance, before they present to the ED. This aligns with the findings from a review on the related concept of same day emergency care, which highlighted that both timely access to diagnostics and accurate identification of suitable patients were key factors for succes [21,22]. Moreover, longstanding reliance on the safety and rapid availability of extensive diagnostic facilities in the ED may further discourage redirection. While evidence on the safety and efficiency of acute outpatient clinics remains limited, the review showed promising results in safely delivering care outside the ED and reducing crowding [22]. To optimise the utilisation of alternative care settings, further research is needed to define the required diagnostic facilities and identify patient profiles most appropriate for such care.

Given these insights, a substantial proportion of ED visits may be preventable or redirectable. Earlier identification of such cases, through consistent criteria across clinicians and healthcare settings, together with proactive management and improved organisation and accessibility of alternative care settings, could help reduce unnecessary ED utilisation, particularly in times of increasing ED crowding and workforce constraints.

Limitations

Several limitations should be considered when interpreting the findings of this study. First, the findings represent descriptive estimates from a single 24‑hour observational snapshot and may therefore not fully capture temporal variation. As an exploratory flashmob study, the results provide a cross-sectional overview of internal medicine ED presentations during the study period and should not be interpreted as generalisable measures of prevalence or healthcare system performance. Moreover although the study aimed to provide a representative overview of ED presentations, general hospitals were underrepresented in comparison to university and teaching hospitals. This imbalance may reflect the limited capacity of general hospitals to participate in time-intensive research such as this flashmob study, potentially introducing bias. However, we do not expect this to have a significant impact on the outcomes. Secondly, even though 28 hospitals participated, only 203 patients were included. Nevertheless, patients were recruited consecutively, and data on internal medicine presentations during the study period from 12 hospitals indicate that the majority of eligible patients were enrolled, with a median inclusion rate of 71.4% (range 44.4–100%). Moreover, data on presentations due to complications of chronic disease, preventable emergency visits, and redirectable visits did not differ between hospitals with inclusion rates below 50% and those with complete (100%) inclusion. Based on these data, selection bias is likely to be limited. The relatively modest number of patients per hospital likely reflects variations in recruitment hours, natural fluctuations in ED attendances, and the fact that not all patients provided consent. Furthermore, these assessments were made retrospectively by the primary responsible physician without predefined criteria, and interobserver variability was not assessed. Consequently, these estimates reflect subjective clinical judgement and may vary between clinicians and healthcare settings. In addition, this approach likely introduced hindsight, optimism, and post-diagnostic reassessment bias, as physicians had access to full diagnostic information at the time of judgement. This may have resulted in an overestimation of potential redirection, as it is often challenging to assess a patient’s condition and care needs prior to arrival at the ED. Nonetheless, this approach provides valuable insight into the potential scope for prevention and redirection of internal medicine ED visits and establishes a foundation for future studies to define criteria for safe prospective redirection as well as to explore opportunities for the development of alternative care pathways. Finally, the organisation of acute care within the Dutch healthcare systems may limit the generalisability of these findings to other healthcare settings with different referral structures or less gatekeeping and 24/7 access to GPs. However, given that demographic changes are occurring worldwide and ED crowding is a global challenge, our findings are still relevant internationally.

Conclusion

This nationwide exploratory study suggests that acute internal medicine care in the ED is often an extension of chronic care, with many patients presenting due to complications of conditions for which they were already being treated. While alternative care pathways exist, their use remains limited, mainly due to organisational barriers. To ensure the right care in the right place at the right time, and safeguard the accessibility of EDs, future efforts must be focused on implementation and the efficient use of available resources.

Supporting information

S1 Questionaire. Organisational characteristics.

(DOCX)

pone.0353157.s001.docx (20KB, docx)
S2 Questionaire. Patient characteristics.

(DOCX)

pone.0353157.s002.docx (20.1KB, docx)
S1 Table. Presenting complaints in the ED.

(DOCX)

pone.0353157.s003.docx (31KB, docx)
S2 Table. Referral to the ED and discharge location.

(DOCX)

pone.0353157.s004.docx (32.2KB, docx)
S3 Table. Contact with hospital healthcare providers 7-days prior to ED visit.

(DOCX)

pone.0353157.s005.docx (24KB, docx)
S4 Table. Possible prevention and redirection of ED presentation in acute on chronic patients.

(DOCX)

pone.0353157.s006.docx (24.1KB, docx)
S5. Table. Sub-analysis: referral patterns and prior hospital contact in preventable ED visits.

(DOCX)

pone.0353157.s007.docx (25.7KB, docx)
S6. Table. Sub-analysis: referral patterns and prior hospital contact in redirectable ED visits.

(DOCX)

pone.0353157.s008.docx (25.8KB, docx)

Acknowledgments

The authors gratefully acknowledge the contributions of the participating hospitals and local investigators of the ORCA (Onderzoeks Consortium Acute Geneeskunde) Acute Medicine Research Consortium, who played an essential role in data collection and local coordination:

ORCA – Acute Medicine Research Consortium

Members of the ORCA consortium are:

Nanayakkara PWB, Amsterdam University Medical Center, location Vu University Medical Center, the Netherlands; Jonkers F, Máxima MC, the Netherlands; Alsma J, Erasmus University Medical Center, the Netherlands; Kremers MNT, Erasmus University Medical Center and Maastricht University and CAPHRI School for Public Health and Primary Care, Aging and Long Term care Maastricht, the Netherlands; Uffen JW, Onze Lieve Vrouwe Hospital, the Netherlands; Groeneveld GH, Leiden University Medical Center, the Netherlands; Carels RA, Ikazia Hospital, the Netherlands; Holleman F, Amsterdam University Medical Center, location AMC, the Netherlands; van Nieuwkoop C, Haga Teaching Hospital, the Netherlands; Hoogerwerf JJ, Radboud University Medical Center, the Netherlands; Kaasjager KHAH, University Medical Center Utrecht, the Netherlands; Minderhoud T, University Medical Center Utrecht, the Netherlands; Dekker D, University Medical Center Utrecht; Schouten WEM, OLVG location East, the Netherlands; Bouma HR, University Medical Center Groningen, the Netherlands; Stassen PM, Maastricht University Medical Center, the Netherlands; van Noord C, Maasstad Hospital, the Netherlands; van Leeuwen-Nguyen HTT, Maasstad Hospital, the Netherlands; Govers A, Sint Franciscus Gasthuis & Vlietland, the Netherlands; Buunk G, Amphia Hospital, the Netherlands; de Regt MJA, OLVG, the Netherlands.

Dr. M.N.T. Kremers will function as lead author, available for correspondence at marjolein.kremers@catharinaziekenhuis.nl.

Local ambassadors are:

• Ziekenhuis Gelderse Vallei: A.M. Tinholt

• Canisius Wilhelmina Ziekenhuis: B.A.J. Veldman

• Reinier de Graaf Gasthuis: S.S. Singh, L.J. Ellerbroek

• Elisabeth–Twee Steden Ziekenhuis: M.A.H. Berrevoets, J. Hogeweg

• Leiden UMC: L. Becude

• Amsterdam UMC: S.C. Bhagirath, A.G. den Hollander

• Van Weel-Bethesda Ziekenhuis: N.A.F. Verheijden

• Sint Jansdal: H. Kabboue

• Sint Jans Gasthuis: D.G.H.A. van Dam

• Groene Hart Ziekenhuis: E.M. Schipper, D.R. Vintges

• Maasstad Ziekenhuis: C. van Noord, N. Engels

• Ommelander Ziekenhuis: D.A.W.A. Joosen, E.F.M.M. van Dijk

• Isala: J.M. Hillen

• Amphia: G. Buunk, P. Mendelaar

• Flevoziekenhuis: J. Branger

• Martini Ziekenhuis: K. van der Heide

• Albert Schweitzer Ziekenhuis: M. Mebius, S. Schol-Gelok

• Diakonessenhuis: S.U.C. Sankatsing, L. Corten

• Haaglanden Medisch Centrum: S. Braken, S. Pasha

• Rijnstate: T.W. Vonder, Dr. A.C. Strang

• MUMC+: P.M. Stassen

• Catharina Ziekenhuis: M.W.L. van Geffen

• Erasmus MC: J.G.A. den Duijn

• St. Antonius Ziekenhuis (Nieuwegein): A.J. Meinders, M. Schinkel

• Radboud UMC: C.C.M. Schaap, R.A.M. Tuinte

• Gelre Ziekenhuizen (locatie Apeldoorn): J. Korenblik

• Máxima MC: F. Jonkers

Each individual has given their permission to be acknowledged here.

Data Availability

Data are available from the corresponding author, Michelle Körnmann (m.n.koernmann@amsterdamumc.nl), or from the Medical Ethics Review Committee (metc@mmc.nl) upon reasonable request. All patients provided informed consent for the collection and use of their data for the purposes of this study; however, consent for public data sharing was not obtained. This approach was reviewed and approved by the local medical ethics committee and privacy officer in accordance with applicable ethical guidelines and regulations.

Funding Statement

This work was supported by a Science Grant of €7,500 from the Dutch Society of Acute Internal Medicine (Nederlandse Vereniging voor Internisten Acute Geneeskunde, NVIAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received from public, commercial, or not-for-profit sectors.

References

  • 1.(NVZ) NVvZ. Position paper Acute zorg. 2022. [Google Scholar]
  • 2.Morley C, Unwin M, Peterson GM, Stankovich J, Kinsman L. Emergency department crowding: a systematic review of causes, consequences and solutions. PLoS One. 2018;13(8):e0203316. doi: 10.1371/journal.pone.0203316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Asplin BR, Magid DJ, Rhodes KV, Solberg LI, Lurie N, Camargo CA Jr. A conceptual model of emergency department crowding. Ann Emerg Med. 2003;42(2):173–80. doi: 10.1067/mem.2003.302 [DOI] [PubMed] [Google Scholar]
  • 4.Savioli G, Ceresa IF, Gri N, Bavestrello Piccini G, Longhitano Y, Zanza C, et al. Emergency department overcrowding: understanding the factors to find corresponding solutions. J Pers Med. 2022;12(2):279. doi: 10.3390/jpm12020279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Schouten B, Merten H, Kremers M, van Greuningen M, Wagner C, Nanayakkara P. Emergency department crowding and older patients: a nationwide retrospective cohort study. Acute Med. 2023;22(2):72–82. doi: 10.52964/AMJA.0938 [DOI] [PubMed] [Google Scholar]
  • 6.Zaboli A, Ziller M, Brigo F, Cipriano A, Pfeifer N, Voza A, et al. The impact of chronic conditions on emergency department length of stay. Intern Emerg Med. 2025. doi: 10.1007/s11739-025-04080-5 [DOI] [PubMed] [Google Scholar]
  • 7.Blayney MC, Reed MJ, Masterson JA, Anand A, Bouamrane MM, Fleuriot J, et al. Multimorbidity and adverse outcomes following emergency department attendance: population based cohort study. BMJ Med. 2024;3(1):e000731. doi: 10.1136/bmjmed-2023-000731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Naik H, Murray TM, Khan M, Daly-Grafstein D, Liu G, Kassen BO, et al. Population-based trends in complexity of hospital inpatients. JAMA Intern Med. 2024;184(2):183–92. doi: 10.1001/jamainternmed.2023.7410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rubio-Fernández E, Rosino-Bosch A, Alonso-Fernández S, Ruiz-Rosino M, García-Sierra RM, Benito-Aracil L, et al. Multidimensional characteristics of complex chronic patients in emergency services in primary care. Collegian. 2023;30(1):94–100. doi: 10.1016/j.colegn.2022.07.007 [DOI] [Google Scholar]
  • 10.NIV. Visie op toekomstbestendige zorg. 2023. [cited 2024]. Available from: https://www.internisten.nl/wp-content/uploads/2023/02/2023-02-6-3a2-NIV-visie-toekomstbestendige-acute-zorg.pdf [Google Scholar]
  • 11.Stassen PM, Cals JWL. Flash mob studies; science in a flash. Ned Tijdschr Geneeskd. 2020;164:D4736. [PubMed] [Google Scholar]
  • 12.(NZA) NZ. Kerncijfers acute zorg 2017-2023. 2024. [Google Scholar]
  • 13.Sabbatini AK, Kocher KE, Basu A, Hsia RY. In-hospital outcomes and costs among patients hospitalized during a return visit to the emergency department. JAMA. 2016;315(7):663–71. doi: 10.1001/jama.2016.0649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gabayan GZ, Asch SM, Hsia RY, Zingmond D, Liang L-J, Han W, et al. Factors associated with short-term bounce-back admissions after emergency department discharge. Ann Emerg Med. 2013;62(2):136–144.e1. doi: 10.1016/j.annemergmed.2013.01.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Buurman BM, Frenkel WJ, Abu-Hanna A, Parlevliet JL, de Rooij SE. Acute and chronic diseases as part of multimorbidity in acutely hospitalized older patients. Eur J Intern Med. 2016;27:68–75. doi: 10.1016/j.ejim.2015.09.021 [DOI] [PubMed] [Google Scholar]
  • 16.Kellett J, Deane B. The diagnoses and co-morbidity encountered in the hospital practice of acute internal medicine. Eur J Intern Med. 2007;18(6):467–73. doi: 10.1016/j.ejim.2007.02.019 [DOI] [PubMed] [Google Scholar]
  • 17.Vest-Hansen B, Riis AH, Sørensen HT, Christiansen CF. Acute admissions to medical departments in Denmark: diagnoses and patient characteristics. Eur J Intern Med. 2014;25(7):639–45. doi: 10.1016/j.ejim.2014.06.017 [DOI] [PubMed] [Google Scholar]
  • 18.Driesen B, Merten H, Barendregt R, Bonjer HJ, Wagner C, Nanayakkara PWB. Root causes and preventability of emergency department presentations of older patients: a prospective observational study. BMJ Open. 2021;11(8):e049543. doi: 10.1136/bmjopen-2021-049543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Verhaegh MTH, Snijders F, Janssen L, Peters NALR, Mol Y, Kamerman-Celie F, et al. Perspectives on the preventability of emergency department visits by older patients. Neth J Med. 2019;77(9):330–7. [PubMed] [Google Scholar]
  • 20.Horney C, Schmader K, Sanders LL, Heflin M, Ragsdale L, McConnell E, et al. Health care utilization before and after an outpatient ED visit in older people. Am J Emerg Med. 2012;30(1):135–42. doi: 10.1016/j.ajem.2010.10.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Atkin C, Perrett M, Cooksley T, Varia R, Holland M, Knight T, et al. Provision of medical same day emergency care services within the UK: analysis from the Society for Acute Medicine Benchmarking Audit. BMJ Open. 2025;15(4):e094580. doi: 10.1136/bmjopen-2024-094580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dean S, Barratt J. What is the existing evidence base for adult medical same day emergency care in UK NHS hospitals? A scoping review protocol. BMJ Open. 2023;13(10):e071890. doi: 10.1136/bmjopen-2023-071890 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mabel Aoun

27 Feb 2026

-->PONE-D-25-68026-->-->FOCUS - Finding Optimal Care in Urgent Settings-->-->PLOS One

Dear Dr. Körnmann,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

The manuscript was assessed by two reviewers and the academic editor. The research question is very relevant given the overcrowded emergency departments worldwide (not only in the Netherlands). However, a major revision of the manuscript is required. Please provide a point-by-point response to reviewers’ comments. The title should follow PLOS ONE requirements and include at the end the design of the study.  The reporting of the methods section needs some improvement. Please clarify in the study design that the study includes two steps, the first assessing patients and the second questioning doctors. Please provide the exact question asked to doctors. Please provide a clear paragraph of major variables collected with definitions especially for the variables included in the tables (what is U0, U1,…etc?).  -->-->==============================

Please submit your revised manuscript by Apr 13 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Aoun, MD, MPH

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

3. One of the noted authors is a group or consortium [Acute Medicine Research Consortium (ORCA) and local investigators]. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly.

5. In the online submission form, you indicated that the data underlying this study contain potentially identifying and sensitive patient information and therefore cannot be publicly shared. This is particularly relevant given the study’s design as a 24-hour snapshot and the relatively small number of patients per hospital and medical specialty, which increases the risk of indirect identification of individual participants.

De-identified data may be made available upon reasonable request, subject to approval by the study steering committee and the relevant ethics committee, and in accordance with applicable data protection regulations. Data access requests should be addressed to the corresponding author.

De-identified data may be made available upon reasonable request, subject to approval by the study steering committee and the relevant ethics committee, and in accordance with applicable data protection regulations. Data access requests should be addressed to the corresponding author.

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

6. Thank you for stating the following financial disclosure:

This work was supported by a Science Grant of €7,500 from the Dutch Society of Acute Internal Medicine (Nederlandse Vereniging voor Internisten Acute Geneeskunde, NVIAG). No additional funding was received from public, commercial, or not-for-profit sectors.

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

7. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

8. Please amend your authorship list in your manuscript file to include author Michelle Noël Körnmann, Elisabeth Margaretha Mols, Harm R. Haak, Jelmer Alsma, Patricia Stassen, Karin Kaasjager, Geert Groeneveld, Marjolein N.T. Kremers.

9. Please amend the manuscript submission data (via Edit Submission) to include author E.M. Mols, M.N. Körnmann, H.R. Haak, J. Alsma, P. Stassen, H.A.H. Kaasjager, G.H. Groeneveld, M.N.T. Kremers.

10. One of the noted authors is a group or consortium [on behalf of the ORCA (Onderzoeks Consortium Acute Geneeskunde) Acute Medicine Research Consortium and local investigators].

In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

11. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

12. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table.

13. Please include a copy of Table 5 which you refer to in your text on page 12.

14. We note that there is identifying data in the Supporting Information file <Studieprotocol_ENG_versie2.pdf >. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.

Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared:

-Name, initials, physical address

-Ages more specific than whole numbers

-Internet protocol (IP) address

-Specific dates (birth dates, death dates, examination dates, etc.)

-Contact information such as phone number or email address

-Location data

-ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order)

Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long.

Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

15. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

16. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Partly

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: No

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Many thanks to the authors for investigating possibilities to relieve pressure from Dutch emergency departments (EDs) by assessing the potential for redirection to alternative acute care settings, providing a foundation fo optimizing the delivery of care in the right place at the right time. Nobody will oppose to that. However, reading the manuscript I have the following remarks and concerns:

INTRODUCTION PART

The authors state a decline in ED visits in recent years. Indeed this is known as a temporary postcovid effect. However, since 2000 the growth of ED-visits is reasonable in line with demographic growth. The post-corona dip has now been overtaken and the pre-corona trend restored.

A more plausible explanation may indeed lie in the increasing complexity of patient care needs, driven by an aging population with multiple health problems.

However, when it comes to pressure on acute care and crowded EDs the authors do not mention anything about landscape changes that have taken place over the last 15 years and played an major role in the rising number of overcrowded EDs and ED diversions. A steady growing total number of ED-visits over the years, with 25% less EDs and an enormous reduction of hospital beds behind the remaining EDs overthe last 15 years. The ED landscape has stiffened.

ED crowding is a complex and systemic problem, expressing itself in the ED. The complexity ED-crowding, if mentioned, should be brought out better.

The authors state that: Traditionally, EDs are not designed to provide care to patients with complex needs, due to their primary focus on trauma care and diagnosis-driven pathways. However, a shift in the acute care landscape had occured, with an increasing number of patients presenting to the ED due to detoriation or complications of pre-existing chronic illnesses.'

True, but 25 - 20 years ago. Since then EDs in the Netherlands have developed long ago to areas of a medical facilities is not adequate for certain devoted to the provision of an organized system of emergency medical care that is staffed by Medical Specialist Physicians and/or Emergency Physicians and has the basis resources to resuscitate, diagnose and treat patients with medical emergencies of any kind (illness, trauma and acute mental issues). The authors paint too modest a picture of the highly and broad professionalized current EDs in the Netherlands, suggesting ED-design is a problem to handle certain presentations. This is not substantiated.

Having made these comments, ofcourse it is good to see whether internal medicine problems can be seen outside the ED safely, cost effective and with enough personel (the biggest tightness).

METHODS

Study design: The authors have chosen for a flashmob-study, which comes with distict limitations regarding scope, data, depth and bias. But I can understand the attractiveness of this method.

Study setting: Not in every ED all patients are registered under a specific traditional specialty. The trend in the Netherlands since formal recognition of the specialty Emergency Medicine in January 2024 is towards registration also under emergency physicians names.

Study population: 'The study included all patients > 18 years presenting t the ED for internal medicine etc.' So prospective included, based upon referral. It is known that a significant part of referred patients end up having another problem then initially thought of and needing treatment of another specialism then referred to. In the Netherlands known to be around 20%. I'm curious how the authors dealt with this in their study.

Study outcomes: '3) The proportion of ED visits that could have been redirected elsewhere in the emergency care chain or prevented, as retrospectively assessed by the treating physician.' First, Retrospectively assessed... The matter is that in practice it needs to be assessed prospectively. How does the retrospective assessment relate to ED/acute care practice? Second, by the treating physician only? On what grounds exactly? Can these be shared in the manuscript? How consistent were these assessments? Were these assessments reviewed by another physician? Can the physicians that actually did the assessments during the 24 hours perion be specified? Role? Experience?

RESULTS

Patient chracteristics: How many patients have been asked to participate and how many refused?

Redirecting urgent care: I reiterate my concerns about the methodology used and as a result these Results.

DISCUSSION

'In this prospective, nationwide flashmob study', Is the addition prospective appropriate?

'in nearly 40%, patients could theoretically have been redirected to alternative acute care settings as judged by the treating physician'. Based on the methodology used this is a too strong statement.

The authors spent a lot of attention on ácute on chronic care' for substantiation much of ED presentations could potentially be seen elsewhere in the hospital. But could they also reflect on what has made all this care being directed to the ED in the first place? What has caused, despite good alternatives (out patient clinics, internal wards, acute medical units), that internal medicne patient flow has shifted to the EDs and away from the alternatives in the first place? Were there good reasons for that? How do the alternatives compare to the ED? I think this perspective might be of added value to the manuscript.

Reviewer #2: Overall Assessment

This manuscript presents a nationwide, prospective multicentre flashmob study conducted across 28 Dutch hospitals, evaluating the proportion of internal medicine emergency department (ED) visits related to chronic conditions and the potential for redirection to alternative acute care settings.

The research question is timely and highly relevant in the context of ED crowding, workforce constraints, and the increasing burden of chronic disease. The flashmob methodology—characterised by short-term, simultaneous, prospective data collection across multiple centres—is innovative and appropriate for capturing a real-time snapshot of acute care delivery at the system level.

Major Comments

1. Flashmob Methodology: Appropriateness and Inherent Constraints

The use of a flashmob design is a central methodological feature of this study (Methods section).

This approach is appropriate for descriptive, system-level questions and allows broad national participation with limited resources. However, the snapshot nature of flashmob studies inherently limits:

• Temporal representativeness (single 24-hour window)

• Seasonal variability

• Weekday vs weekend variation

• Causal inference

• Precision of subgroup analyses

While some limitations are acknowledged, the Discussion should more explicitly emphasise that the findings represent exploratory, descriptive estimates rather than definitive national prevalence measures.

Explicitly framing the study as a system-level observational snapshot would strengthen methodological coherence and interpretation.

2. Subjectivity of Key Outcomes (Preventability and Redirection)

A key outcome—whether ED visits were “preventable” or “redirectable”—was determined retrospectively by the treating physician after ED evaluation.

This introduces:

• Hindsight bias

• Optimism bias

• Post-diagnostic reassessment bias

Because physicians had access to full diagnostic information at the time of judgement, these assessments may overestimate theoretical redirection feasibility.

Although acknowledged in the Limitations section, this issue should be more prominently integrated into the interpretation of the main results and conclusion.

3. External Generalisability

The study is conducted within the Dutch healthcare system, characterised by:

• Strong GP gatekeeping

• Structured referral systems

• Developed outpatient acute care infrastructure

These features significantly influence ED utilisation patterns.

The authors should more clearly discuss how these system characteristics may limit generalisability to:

• Open-access ED systems

• Healthcare environments with weaker primary care integration

• Different reimbursement models

Broader policy implications should therefore be framed cautiously and contextually.

Minor Comments

1. Comment on the Title

While “FOCUS – Finding Optimal Care in Urgent Settings” is a memorable study acronym, the current title does not clearly convey the study population, setting, design, or main outcomes. In its present form, it provides limited information about the focus on internal medicine emergency department presentations, chronic disease–related visits, and the assessment of potential redirection to alternative acute care settings. I recommend revising the title to be more descriptive and informative, in line with PLOS ONE’s preference for titles that clearly reflect the content and scope of the study.

2. Abstract and Language

• In the Abstract (p. 10), “EDs are face increasing pressure” should be corrected to “EDs are facing increasing pressure.”

• Ensure consistent use of terminology throughout the manuscript (e.g., “acute on chronic,” “preventable,” “redirectable”).

3. Tables

• Tables 1–3 contain valuable information but are relatively dense. Consider condensing selected organisational details in Table 1 (p. 16) or relocating some elements to Supplementary Material to improve readability.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Jul 15;21(7):e0353157. doi: 10.1371/journal.pone.0353157.r002

Author response to Decision Letter 1


11 Apr 2026

Response to reviewers

Dear editor and reviewers,

We would like to sincerely thank you and the reviewers for your careful evaluation of our manuscript and for the constructive and insightful comments provided. We greatly appreciate the time and effort invested in reviewing our work. The feedback has helped us to significantly improve the clarity, transparency, and overall quality of the manuscript.

We have revised the manuscript thoroughly in accordance with all editorial and reviewer comments. We provided a structured summary of the major revisions made in the response to the reviewers letter.

We believe that these revisions have substantially strengthened the manuscript and addressed all concerns raised. We hope that the revised version meets the journals standards for publication.

Thank you again for your consideration.

Sincerely,

M.N. Körnmann & E.M. Mols

Attachment

Submitted filename: FOCUS Response to Reviewers.docx

pone.0353157.s011.docx (50KB, docx)

Decision Letter 1

Mabel Aoun, Vijayaprakash Suppiah

8 Jun 2026

-->PONE-D-25-68026R1-->-->Chronic disease related emergency department presentations and potential for redirection to alternative acute care settings (“FOCUS” study): a nationwide flashmob study-->-->PLOS One

Dear Dr. Körnmann,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS One

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #2: (No Response)

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #2: (No Response)

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #2: (No Response)

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: (No Response)

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #2: (No Response)

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #2: (No Response)

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

Attachment

Submitted filename: PONE-D-25-68026 2nd review.docx

pone.0353157.s010.docx (14.4KB, docx)
PLoS One. 2026 Jul 15;21(7):e0353157. doi: 10.1371/journal.pone.0353157.r004

Author response to Decision Letter 2


18 Jun 2026

Dear Editor and Reviewers,

We would like to thank you for your careful evaluation of the revised manuscript and for your additional constructive comments. We appreciate the opportunity to further improve our work.

We have revised the manuscript accordingly and have addressed all remaining comments. A detailed point-by-point response is provided in the Response to Reviewers document.

We hope that the revised manuscript satisfactorily addresses the reviewers’ concerns and is now suitable for publication.

Thank you again for your consideration.

Sincerely,

M.N. Körnmann & E.M. Mols

On behalf of all authors

m.n.koernmann@amsterdamumc.nl

Attachment

Submitted filename: FOCUS_Response_to_Reviewers_auresp_2.docx

pone.0353157.s012.docx (31KB, docx)

Decision Letter 2

Mabel Aoun, Vijayaprakash Suppiah, Vijayaprakash Suppiah

21 Jun 2026

Chronic disease related emergency department presentations and potential for redirection to alternative acute care settings (“FOCUS” study): a nationwide flashmob study

PONE-D-25-68026R2

Dear Dr. Körnmann,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS One

Acceptance letter

Mabel Aoun, Vijayaprakash Suppiah, Vijayaprakash Suppiah

PONE-D-25-68026R2

PLOS One

Dear Dr. Körnmann,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vijayaprakash Suppiah

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Questionaire. Organisational characteristics.

    (DOCX)

    pone.0353157.s001.docx (20KB, docx)
    S2 Questionaire. Patient characteristics.

    (DOCX)

    pone.0353157.s002.docx (20.1KB, docx)
    S1 Table. Presenting complaints in the ED.

    (DOCX)

    pone.0353157.s003.docx (31KB, docx)
    S2 Table. Referral to the ED and discharge location.

    (DOCX)

    pone.0353157.s004.docx (32.2KB, docx)
    S3 Table. Contact with hospital healthcare providers 7-days prior to ED visit.

    (DOCX)

    pone.0353157.s005.docx (24KB, docx)
    S4 Table. Possible prevention and redirection of ED presentation in acute on chronic patients.

    (DOCX)

    pone.0353157.s006.docx (24.1KB, docx)
    S5. Table. Sub-analysis: referral patterns and prior hospital contact in preventable ED visits.

    (DOCX)

    pone.0353157.s007.docx (25.7KB, docx)
    S6. Table. Sub-analysis: referral patterns and prior hospital contact in redirectable ED visits.

    (DOCX)

    pone.0353157.s008.docx (25.8KB, docx)
    Attachment

    Submitted filename: FOCUS Response to Reviewers.docx

    pone.0353157.s011.docx (50KB, docx)
    Attachment

    Submitted filename: PONE-D-25-68026 2nd review.docx

    pone.0353157.s010.docx (14.4KB, docx)
    Attachment

    Submitted filename: FOCUS_Response_to_Reviewers_auresp_2.docx

    pone.0353157.s012.docx (31KB, docx)

    Data Availability Statement

    Data are available from the corresponding author, Michelle Körnmann (m.n.koernmann@amsterdamumc.nl), or from the Medical Ethics Review Committee (metc@mmc.nl) upon reasonable request. All patients provided informed consent for the collection and use of their data for the purposes of this study; however, consent for public data sharing was not obtained. This approach was reviewed and approved by the local medical ethics committee and privacy officer in accordance with applicable ethical guidelines and regulations.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES